The Food and Drug Administration (FDA) announced Wednesday that it has rescinded the emergency use authorizations (EUAs) for COVID-19 vaccines, formally ending the framework that allowed millions of Americans to be vaccinated quickly during the height of the pandemic.
Health and Human Services Secretary Robert F. Kennedy Jr. revealed the move in a social media post, framing it as the fulfillment of his pledge to dismantle vaccine mandates and overhaul federal health policy. “We accomplished four goals today,” Kennedy wrote, “to end the emergency, end mandates, keep vaccines available for those who want them, and demand stronger trials from companies.”
From Universal to Restricted
The change represents a dramatic shift in how COVID vaccines will be distributed. Under the rescinded EUAs, vaccines were accessible to nearly everyone, including healthy children. Now, the FDA has narrowed the scope of who qualifies.
- Pfizer-BioNTech (Comirnaty) is now authorized only for adults 65 and older, and for people aged 5 to 64 with at least one high-risk condition.
- Moderna’s vaccine is permitted for children as young as 6 months, but only those considered medically vulnerable.
- Novavax is available for ages 12 and up, again under similar restrictions.
Unlike during the pandemic, individuals will not be able to simply walk into a pharmacy or school clinic to receive the shot. Instead, vaccinations will require a doctor’s consultation, shifting COVID immunization into a more traditional medical setting.
A Long Road from 2020
The EUAs were first issued in late 2020 when no fully approved vaccines were available. At that time, the urgency of the pandemic allowed the FDA to distribute vaccines under a lower evidentiary threshold — that their potential benefits outweighed the risks.
Pfizer’s and Moderna’s vaccines eventually received full FDA approval in 2021 and 2022. But the EUA framework persisted as a way to authorize doses for broader populations, including younger children. That emergency umbrella has now been formally closed.
The Biden administration had already declared the end of the COVID public health emergency in May 2023, but EUAs for vaccines lingered as a regulatory tool. With Kennedy’s announcement, that chapter has ended.
Divided Reactions
The move has sparked sharply divided responses.
Supporters of Kennedy’s decision argue that rescinding EUAs restores public trust and individual freedom. To them, the end of mandates and emergency provisions marks a return to normalcy.
Critics, however, see the restrictions as dangerous backsliding. Major medical organizations, including the American Academy of Pediatrics, continue to recommend COVID immunization for all children, not just those with underlying health conditions. They warn that scaling back access leaves communities vulnerable, particularly as new variants emerge.
“This decision undermines years of progress,” said Dr. Emily Porter, a pediatric infectious disease specialist. “The virus hasn’t gone away, and restricting vaccines to only high-risk groups leaves millions unprotected.”
What This Means for Families
For parents, the impact is immediate. Under the new rules, healthy children will no longer be routinely eligible for COVID vaccination. Families must now rely on individual consultations, and many will face uncertainty as schools begin their fall terms.
Meanwhile, for older adults and those with medical conditions, the vaccines remain available — but only through healthcare providers. Pharmacies that once administered millions of shots under EUA guidelines may now see their role diminish.
Insurance companies are also scrambling to adapt. While most federally recommended vaccines are covered at no cost, the narrower eligibility may complicate reimbursement policies, especially for families outside the high-risk categories.
Kennedy’s Broader Agenda
Wednesday’s announcement is part of a broader campaign by Kennedy to reshape federal public health policy. Long a vocal critic of vaccine mandates, he has positioned himself as a champion of personal choice while calling for placebo-controlled clinical trials before future approvals.
In 2021, Kennedy petitioned the FDA to rescind EUAs, a request that was rejected at the time. Four years later, as head of HHS, he now has the power to make that vision a reality.
A Nation Still Split
For much of the country, the decision reopens wounds that never fully healed during the pandemic. To many, vaccines symbolized survival and scientific progress. To others, they became symbols of government overreach.
Now, with the emergency lifted and authorizations rescinded, the legacy of America’s COVID vaccination campaign enters a new and contested phase.
In Minneapolis, Boston, and Dallas, small demonstrations broke out within hours of the announcement — some applauding, others demanding reversal. “This isn’t just about science,” one protester told local reporters. “It’s about who we trust to protect our kids.”
Looking Ahead
The rescission of EUAs does not mean COVID vaccines are gone. For millions of Americans considered vulnerable, the shots remain available. But the symbolic weight of Wednesday’s decision cannot be overstated: a declaration that the pandemic era is officially over, and with it, the emergency tools once used to fight it.
Whether that leaves the country safer or more exposed will be tested in the months ahead, as the virus continues its unpredictable path through an America still deeply divided over how to confront it.
